HDFC Securities' research report on Marico
Marico posted a mixed set of numbers as revenue declined 11% YoY due to weak domestic performance. Domestic revenue/EBIT declined by 15/2% YoY, while International revenue/EBIT grew by 2/18% YoY. The domestic performance was impacted by weak demand in VAHO (-32% YoY) and PCNO (-12% YoY). Saffola continued its strong trajectory with 16% YoY growth. The company has witnessed a sequential recovery in demand in May and June, recording a 3% YoY growth. In international, Bangladesh posted healthy 10% YoY cc growth while the lockdowns in MENA (-27% YoY cc) and South Africa (-25% YoY cc) impacted international revenue (-4% YoY cc). There is a beat at the EBITDA level, led by lower A&P. Benign copra prices and A&P rationalisation will maintain operating margins at a healthy level in FY21. While we expect the discretionary portfolio to remain muted, PCNO and Saffola are expected to drive recovery.
Outlook
We maintain our EPS for FY21/FY22/FY23. We value Marico at 35x P/E on Jun-22E EPS and derive a target price of Rs 351. Maintain REDUCE.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.